Old Web
English
Sign In
Acemap
>
authorDetail
>
Nazaret Cordero Franco
Nazaret Cordero Franco
Medicine
Internal medicine
Physical therapy
Oncology
Bevacizumab
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
La inmunosupresión como causa del cáncer: Presentación de un caso y revisión de la terapia inmunosupresora en pacientes con trasplante renal
2019
Andrea Silva Asiain
Begona Martinez Carrasco
Nazaret Cordero Franco
Maria Blazquez Arroyo
Antonio Gallegos Polonio
Javier Prato Varela
Ana G. Ageitos
Show All
Source
Cite
Save
Citations (0)
Tumor sincrónico como entidad clínica: Presentación de un caso clínico y revisión bibliográfica
2019
Rodrigo Perea
Ana G. Ageitos
Begona Martinez Carrasco
Maria Blazquez Arroyo
Nazaret Cordero Franco
Javier Prato Varela
Antonio Gallegos Polonio
Sergio Carrasco
Show All
Source
Cite
Save
Citations (0)
Docetaxel-carboplatin-bevacizumab (TCV): A novel combination that promises a high activity in triple-negative breast cancer: A pilot study.
2017
Journal of Clinical Oncology
Jose Ignacio Chacon
Ana Rosa Rubio Salvador
Nazaret Cordero Franco
Begona Martinez Carrasco
Sonia Alonso Soler
Laura Díaz Paniagua
Lourdes Fernández Franco
Alberto San Juan del Moral
Carmen Esteban
Paloma Moya Gomez
Miguel Ángel Cruz Mora
Show All
Source
Cite
Save
Citations (1)
Would warning of osteonecrosis of the jaw (ONJ) have induced a change in the administration schedule of zoledronic acid (ZA)? A report from Toledo, Spain.
2017
Journal of Clinical Oncology
Ana Rosa Rubio Salvador
Jose Ignacio Chacon
Enriqueta Muñoz-Platón
Begona Martinez Carrasco
Nazaret Cordero Franco
José Manuel Martínez Sesmero
Laura Díaz Paniagua
Sonia Alonso Soler
Alberto San Juan del Moral
Lourdes Fernández Franco
Carmen Esteban
Paloma Moya Gomez
Miguel Ángel Cruz Mora
Show All
Source
Cite
Save
Citations (0)
1